Enanta Pharmaceuticals
ENTA
S$10.33
Share price
8.51%
Change (1 day)
-49.97%
Change (1 year)
Categories
Market capitalization of Enanta Pharmaceuticals (ENTA)
Market cap: S$0.22 Billion
As of July 2025 Enanta Pharmaceuticals has a market cap of S$0.22 Billion. This makes Enanta Pharmaceuticals the world's 8721th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Enanta Pharmaceuticals from 2013 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | S$0.22 B | 27.51% |
| 2024 | S$0.17 B | -33.84% |
| 2023 | S$0.26 B | -79.82% |
| 2022 | S$1.29 B | -37.43% |
| 2021 | S$2.07 B | 85.37% |
| 2020 | S$1.11 B | -32.22% |
| 2019 | S$1.64 B | -12.26% |
| 2018 | S$1.88 B | 25.28% |
| 2017 | S$1.50 B | 62.6% |
| 2016 | S$0.92 B | 5.16% |
| 2015 | S$0.87 B | -29.8% |
| 2014 | S$1.25 B | 101.4% |
| 2013 | S$0.62 B |
End of Day market cap according to different sources
On Jul 28th, 2025 the market cap of Enanta Pharmaceuticals was reported to be:
S$0.22 Billion
S$0.22 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 AbbVie ABBV | S$432.27 B | 195,706.82% | 🇺🇸 USA |
 Johnson & Johnson JNJ | S$514.84 B | 233,109.86% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | S$152.19 B | 68,840.83% | 🇺🇸 USA |
 Merck MRK | S$271.46 B | 122,866.58% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | S$126.75 B | 57,317.22% | 🇺🇸 USA |
 Novartis NVS | S$289.25 B | 130,923.41% | 🇨🇭 Switzerland |